Asp-Arg-Val-Tyr-Val-
His-Pro-Phe (M.W. 1032.2) C49H69N13O12 [58-49-1] D.F. Elliot and W.S. Peart, Nature, 177, 527 (1956). (Original; Heterogenous Renin) H. Akagi, T. Hayashi, T. Nakayama, T. Nakajima, T.X. Watanabe, and H. Sokabe, Chem. Pharm. Bull., 30, 2498 (1982). (Original; Homologous Renin) I.H. Page and F.M. Bumpus (eds.), Angiotensin, Handbook of Experimental Pharmacology, Vol. 37, Springer-Verlag, Berlin, 1974. (Review) M.J. Peach, Physiol. Rev., 57, 313 (1997). (Review) * The biological activity of these peptides is examined by the Division of Pharmacology, Peptide Institute, Inc.
Asp-Arg-Val-Tyr-Val-His-Pro-Phe (M.W. 1032.2) C49H69N13O12 [58-49-1] D.F. Elliot and W.S. Peart, Nature, 177, 527 (1956). (Original; Heterogenous Renin) H. Akagi, T. Hayashi, T. Nakayama, T. Nakajima, T.X. Watanabe, and H. Sokabe, Chem. Pharm. Bull., 30, 2498 (1982). (Original; Homologous Renin) I.H. Page and F.M. Bumpus (eds.), Angiotensin, Handbook of Experimental Pharmacology, Vol. 37, Springer-Verlag, Berlin, 1974. (Review) M.J. Peach, Physiol. Rev., 57, 313 (1997). (Review) * The biological activity of these peptides is examined by the Division of Pharmacology, Peptide Institute, Inc.
![[Val5]-Angiotensin II (0.5 mg vial) - PAN-4034-v - 1 Ea - Peptides International, Inc.](https://partimages.globalspec.com/28/4628/1869628_medium.png)
